Kevin Lye, MD, MBA

Dr. Kevin Lye, MD, MBA has held a variety of positions in the medical field since 2007. Kevin began their career at Tissue Genesis, Inc. as Director of Clinical Research in 2007. In 2013, they joined Pono Pharma as VP and Chief Medical Officer. In 2015, they moved to Northwest Biotherapeutics as VP, Medical Affairs. In 2016, they held the role of Chief Medical Officer at YGEIA Group and iFirst Medical Technologies. In 2018, they served as Chief Medical Officer and Strategy and Innovation Officer at Incubar LLC and Colorado Therapeutics LLC, and as Strategy and Innovation Officer at Colibri Heart Valve. Kevin currently holds the role of Partner at GUILD Consulting.

Kevin Lye, MD, MBA has an extensive educational background. Kevin earned a Doctor of Medicine (MD) from Wake Forest School of Medicine, a Master of Business Administration (MBA) from Hawaii Pacific University, and three Bachelor of Science (BS) degrees from North Carolina State University in Mathematics (with Honors), Biochemistry, and Biology, as well as a Bachelor of Arts (BA) in Chemistry. Kevin also graduated from Needham Broughton High School.